LAUSR

Key Points Question What are patients’ preferences for use of statin therapy for primary prevention across the spectrum of estimated 10-year atherosclerotic cardiovascular disease risk? Findings Of the 304 adults who participated in this survey study, the proportion who would want statin therapy after reviewing personalized benefit and harm information was 51% or less for risk categories under 20%. The minimum risk threshold had to increase to 20% before 75% of respondents in that risk group would want statin therapy. Meaning The results of this survey did not note a risk threshold that would justify a standard for or against the use of statin therapy; the preference distribution suggests a broad range of atherosclerotic cardiovascular disease risk to recommend shared decision-making.